No insider purchase over the last 90 days. The latest was filed 13 Mar 2025.
Chimera Investment Corp is a Real Estate company. Its directors and officers file their transactions with SEC (Form 4). 10 insiders have disclosed 19 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 19 filings, this issuer sits below that mark. Over the whole record (from 2021), the tally stands at 5 purchases and no sales. For the fiscal year to 31 December 2025, the annual 10-K puts net income at 230.5 m USD, and the dividend at 1.48 USD per share.
Over the last twelve months, not one insider purchase of Chimera Investment Corp stock was filed. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4.
For comparison within the same sector, see the insider buying recorded at Simon Property Group Inc /DE/ and Angel Oak Mortgage REIT, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Chimera Investment Corp Hold (neutral), based on 3 analysts. Average price target: US$14.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 107 declarations
Chimera Investment Corporation is a U.S.-listed real estate investment trust (REIT) traded on the NYSE, with its preferred shares referenced here under ticker CIM-PD and its common stock trading as CIM on the NYSE. The company is headquartered in New York, United States, at 520 Madison Avenue, 32nd Floor. Chimera was incorporated in Maryland on June 1, 2007, and began trading on the NYSE in November 2007. It is structured as an internally managed REIT, which is important for investors because its model is centered on distributing income and managing mortgage-related risk inside the operating platform rather than through an external manager. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001409493/000140949326000017/cim-20251231.htm?utm_source=openai))
From a business-model perspective, Chimera is not a traditional property owner. Instead, it is a mortgage-credit specialist focused on residential real estate finance. The company’s stated objective is to generate attractive risk-adjusted returns and distributable income through investments linked to mortgage credit fundamentals. Historically, its portfolio has been concentrated in residential mortgage loans, Agency RMBS, and Non-Agency RMBS, giving Chimera a profile that is highly sensitive to mortgage spreads, prepayment behavior, credit performance, financing costs, and the direction of interest rates. In other words, its competitive edge depends less on physical real estate operations and more on credit selection, leverage discipline, and portfolio management. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001409493/000140949325000021/pressrelease-q32025.htm?utm_source=openai))
A major strategic development in 2025 was the acquisition of HomeXpress Mortgage Corp., completed on October 1, 2025. This transaction materially broadened Chimera’s platform by adding mortgage origination capabilities. Through HomeXpress, Chimera primarily originates non-QM residential mortgage loans, including consumer loans and Investor Loans, plus a smaller amount of QM residential mortgage loans. That acquisition makes the company more vertically integrated and potentially less reliant on passive securities-only exposure, while also increasing operational complexity and execution risk. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1409493/000140949326000017/cim-20251231.htm?utm_source=openai))
For investors in France, Belgium, and Switzerland, Chimera is best viewed as a specialized U.S. mortgage REIT rather than a broad diversified real estate company. Its market position sits within a competitive U.S. mortgage REIT universe where funding access, book-value stability, and credit performance are key differentiators. Recent company updates in 2025 and 2026 point to a transition phase: Chimera emphasized diversification and earnings growth after the HomeXpress deal, while continuing to signal dividend support on the common stock in a volatile market backdrop. That combination suggests a company trying to evolve from a pure mortgage-asset investor into a more integrated residential credit platform. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001409493/000140949325000021/pressrelease-q32025.htm?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | n.d. | 230.5 m USD | 1.72 USD | 1.48 USD | 10-K |
| Dec 2024 | n.d. | 176.1 m USD | 1.10 USD | 1.42 USD | 10-K |
| Dec 2023 | n.d. | 126.1 m USD | 0.68 USD | 2.10 USD | 10-K |
| Dec 2022 | n.d. | -513.1 m USD | -7.53 USD | 1.12 USD | 10-K |
| Dec 2021 | n.d. | 670.1 m USD | 2.44 USD | 1.29 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.